Evidence map›Paper›PMID 36275690›Full record

ArticleFrontiers in immunology2022

Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.

Ziquan Sun, Guodong Li, Desi Shang, Jinning Zhang, Lianjie Ai, Ming Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ziquan SunColorectal Cancer Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Guodong LiDepartment of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Desi ShangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Jinning ZhangColorectal Cancer Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lianjie AiColorectal Cancer Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ming LiuColorectal Cancer Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colon adenocarcinoma (COAD) is a prevalent malignancy that causes significant mortality. Microsatellite instability plays a pivotal function in COAD development and immunotherapy resistance. However, the detailed underlying mechanism requires further investigation. Consequently, identifying molecular biomarkers with prognostic significance and revealing the role of MSI in COAD is important for addressing key obstacles in the available treatments. Methods: CIBERSORT and ESTIMATE analyses were performed to evaluate immune infiltration in COAD samples, followed by correlation analysis for MSI and immune infiltration. Then, differentially expressed genes (DEGs) in MSI and microsatellite stability (MSS) samples were identified and subjected to weighted gene co-expression network analysis (WGCNA). A prognostic model was established with univariate cox regression and LASSO analyses, then evaluated with Kaplan-Meier analysis. The correlation between the prognostic model and immune checkpoint inhibitor (ICI) response was also analyzed. Results: In total, 701 significant DEGs related to MSI status were identified, and WGCNA revealed two modules associated with the immune score. Then, a seven-gene prognostic model was constructed using LASSO and univariate cox regression analyses to predict survival and ICI response. The high-risk score patients in TCGA and GEO cohorts presented a poor prognosis, as well as a high immune checkpoint expression, so they are more likely to benefit from ICI treatment. Conclusion: The seven-gene prognostic model constructed could predict the survival of COAD and ICI response and serve as a reference for immunotherapy decisions.

Indexed as

AdenocarcinomaColonic NeoplasmsBiomarkers, TumorHumansImmune Checkpoint InhibitorsMicrosatellite InstabilityPrognosisBiomarkers, TumorImmune Checkpoint Inhibitorscolon adenocarcinoma (COAD)drug responseimmune microenvironmentmicrosatellite instability (MSI)prognostic biomarkers

Identifiers

PMID36275690
PMCPMC9585257
OpenAlexW4303044297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.